Aflac Q3 2026 Earnings Results & Report

Aflac EPS Results

• Actual EPS: $2.43
• Consensus EPS: $1.80
• Beat/Miss: Beat by +$0.63
• One Year Ago EPS: $2.49
• EPS Beat Rate: 3 of last 8 quarters

Aflac Revenue Results

• Actual Revenue: $3.27 billion
• Expected Revenue: $4.12 billion
• Beat/Miss: Missed by -$848.02 million
• YoY Revenue Growth: -31.00%

Aflac (NYSE:AFL) (NYSE:AFL) is an insurance company specializing in supplemental health and life insurance. Through its policies, the company helps individuals and families manage expenses that may not be fully covered by major medical insurance, including deductibles, copayments and other out-of-pocket costs.

Aflac offers products such as accident, cancer, critical illness, hospital indemnity, dental and vision, disability, life and long-term care insurance. Many of its supplemental policies provide cash benefits directly to policyholders, who can generally use the funds according to their individual needs. The company also provides employee benefits products through workplace-based distribution channels.

Founded in 1955 as American Family Life Assurance Company of Columbus, Aflac serves customers primarily in the United States and Japan. Its U.S. operations focus on supplemental insurance and workplace benefits, while its Japanese operations offer products including medical, cancer, life and other insurance coverage. Virgil R. Miller serves as president and chief executive officer, and Daniel P. Amos serves as executive chairman.